Fiche publication
Date publication
novembre 2025
Journal
International journal of molecular sciences
Auteurs
Membres identifiés du Cancéropôle Est :
Dr THOMPSON Julie
Tous les auteurs :
Simon A, Gineste C, Reiss D, Thompson JD, Laporte J
Lien Pubmed
Résumé
Centronuclear and myotubular myopathies (CNMs) are rare, inherited muscle disorders characterized by muscle atrophy, weakness, and altered muscle fiber structure, primarily caused by mutations in , , or . The molecular mechanisms driving CNM are only partially understood, and no curative therapies are available. To elucidate molecular pathways involved in CNMs, we present an integrative multi-omics analysis across several CNM mouse models untreated or treated with pre-clinical strategies, combining transcriptomic, proteomic, and metabolomic datasets with curated interaction, metabolic, tissue, and phenotype knowledge using network-based approaches. Weighted Gene Co-expression Network Analysis (WGCNA) identified gene modules commonly altered in three CNM genetic forms. Modules correlated with improved muscle function were enriched for processes such as muscle contraction, RNA metabolism, and oxidative phosphorylation, whereas modules linked to disease severity were enriched for immune response, innervation, vascularization, and fatty acid oxidation. We further integrated transcriptomic, proteomic, and metabolomic data from the mouse model with public knowledge bases into a multilayer network, and explored it using a random walk with restart approach. These analyses highlighted metabolites closely connected to CNM phenotypes, some of which may represent candidates for nutritional or pharmacological modulation. Our findings illustrate how integrative multi-omics and network analyses reveal both pathogenic and protective pathways in CNM and provide a foundation for identifying novel therapeutic opportunities.
Mots clés
biomarker, centronuclear myopathy, congenital myopathy, gene co-expression, myotubular myopathy, network-based analysis, omics, skeletal muscle, systems biology, therapeutic target
Référence
Int J Mol Sci. 2025 11 28;26(23):
